All In MedTech

Device Trial Radar · NCT06121856

Project VerioVue Enhancements - Arterial Study

VerioVue Enhancements Regulatory Clinical Evaluation - Professional Comparison to Validated Method: Arterial Study

Last checked: Nov 20, 2026Latest source record: Nov 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

116

Actual

Start

Feb 7, 2023

Primary completion

Apr 28, 2023

Study completion Apr 28, 2023

Sponsor

Lead sponsor
LifeScan Scotland LtdNot on our public-company list
Sponsor type
Industry
First posted
Nov 8, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this performance evaluation is to compare the blood glucose results obtained using the VerioVue Blood Glucose Monitoring System (BGMS) with those obtained from a validated comparator method (iSTAT 1 Analyser) using arterial blood. The main question the study aims to answer is: How accurate is the VerioVue BGMS when compared to a product that has already been confirmed as accurate (iSTAT 1 Analyser) when hospital staff test arterial blood on these two types of instrument? Participants will have a small amount of blood taken from an existing arterial line.

Conditions

  • Diabetes Mellitus

Interventions

  • VerioVue Enhancements BGMSDevice

    Blood glucose monitoring system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance evaluation: blood glucose monitoring system accuracy: BGMS vs reference instrument using arterial bloodTime frame: Within 30 minutes of arterial blood sample draw.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Royal Infirmary of Edinburgh

    Edinburgh, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.